Company intelligence / Profile preview

Synoligo Biotechnologies

Morrisville, North Carolina, United Statessynoligo.com ↗

Ownership: Private
Development stage: Commercial

Overview

Synoligo Biotechnologies is an active commercial supplier specializing in high-quality custom synthesis of complex and highly modified oligonucleotides at varying scales. It serves academic institutions, biotech startups, large pharmaceutical companies as well as diagnostic developers. The company has rapidly expanded since its founding in July 2022—including opening new facilities to increase production capacity—and is recognized for fast turnaround times and expertise with challenging modifications[1][3][4].

Modalities: Antisense oligonucleotideAptamerSmall interfering RNAGuide RNA therapySynthetic oligonucleotide
Industry: Chemicals & Materials

Partnerships

Lumiphore Inc. (for luminescent lanthanide-based reporter technology used in diagnostic/life science assays)

Beyond the preview

Go deeper on Synoligo Biotechnologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Synoligo Biotechnologies.